[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Ali A., Lima Sampaio T., Khan H., Jeandet P., Kupeli Akkol E., Bahadar H., Costa Martins A.M
Goedert, M
Immunometabolic interplay in the tumor microenvironment
Regarding weight loss, the FDA has approved these drugs for people whose body mass index (BMI) is greater than 30 kg/m2, or they have a BMI that is greater than 27 and have a weight-related health problem, such as high blood pressure, sleep apnea, or pre-diabetes
Eating smaller meals, drinking more water, and avoiding fizzy drinks can help
GLP1 receptor agonists may cause gastrointestinal side effects (nausea, vomiting)